The Japanese Society of Hematology adopted and implemented in 2010 the COI Policy and the Bylaws which have been developed in cooperation with 14 societies related to internal medicine (The Japanese Society of Internal Medicine, The Japanese Society of Gastroenterology, The Japanese Society of Hepatology, The Japanese Circulation Society, The Japan Endocrine Society, The Japan Diabetes Society, The Japanese Society of Nephrology, The Japanese Respiratory Society, Societas Neurologica Japonica, The Japan Society of Allergology, The Japan College of Rheumatology, The Japan Association for Infectious Diseases, The Japan Geriatrics Society and The Japanese Society of Hematology).
If a member or non-member presenter will make presentations or lecture on his/her clinical research at a conference organized by the Japanese Society of Hematology, the presenting author is required to report any financial relationship of all authors with any commercial entities or for-profit organizations related to the clinical research within the previous 12 months. The definition of "clinical research" includes all phases of clinical trial and pre-clinical research.
At the time of abstract submission
The presenting author is required to report applicable COI of not only the presenting author, but also all co-authors. In the case that there is any relevant financial relationship to disclose, submit the COI form to the JSH office below before your presentation.
At the time of presentation
The presenting author is required to disclose applicable COI of all authors by displaying a COI disclosure slide at the beginning of presentation slides (the slide after the title of presentation and the name of presenters) or at the end of a poster using samples below.
Refer to 'Article 2' of the Bylaws below for criteria of self-reported COI disclosure.
To read the PDF file you will need Adobe Acrobat Reader DC installed on your computer.